Cosentyx unoready 300 MG pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FFK2T
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,814
Award facts
- Contract value 100% obligated
- $17,813.69 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $17,813.69 by the Defense Logistics Agency on January 7, 2026, for the supply of Cosentyx (secukinumab) 300 mg pen 2 mL injections. The contract is a firm fixed-price delivery order with no set-aside designation, indicating it was awarded through open competition. Performance will be executed at the company's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of January 8, 2026. This delivery order represents a task order under Amerisourcebergen's larger Indefinite Delivery Contract with the Defense Logistics Agency Troop Support Medical, which is valued at up to $999,999,999.00 and extends through December 2026.
Amerisourcebergen Drug Corp serves as a critical pharmaceutical distributor supporting the Defense Logistics Agency's medical supply chain, providing a comprehensive range of medications and medical commodities to military healthcare systems worldwide. The parent company, Cencora, Inc., maintains the primary relationship with the DLA and manages a significant pharmaceutical portfolio covering multiple therapeutic domains including specialty medications, vaccines, and brand-name drugs. The Cosentyx supply order fulfills ongoing military healthcare procurement needs through the established prime vendor relationship, demonstrating the contractor's continued capability to meet federal medical supply requirements on a competitive basis.
Quick answers
Who was awarded contract SPE2DR26FFK2T?
SPE2DR26FFK2T was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 7, 2026.
How much is contract SPE2DR26FFK2T worth?
The government has obligated $17,814 on SPE2DR26FFK2T.
Is contract SPE2DR26FFK2T an order under another contract?
Yes. SPE2DR26FFK2T is a delivery order under SPE2DR25D1109, an indefinite delivery contract.
Was contract SPE2DR26FFK2T competed?
The extent of competition for SPE2DR26FFK2T was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award